已收盘 04-02 16:00:00 美东时间
-0.470
-3.25%
今日重点评级关注:Canaccord Genuity:维持Generac控股"买入"评级,目标价从275美元升至300美元;Oppenheimer:维持Biogen"跑赢大市"评级,目标价从250美元升至275美元
04-02 16:17
MiniMed shows improved pipeline and valuation upside as insulin pump adoption grows despite rising competition and past share losses.
04-01 22:15
今日重点评级关注:Maxim Group:上调Theriva Biologics评级至"买入",目标价1美元;HC Wainwright & Co.:维持Bicara Therapeutics"买入"评级,目标价从40美元升至42美元
04-01 16:34
BTIG analyst Marie Thibault initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $25.
03-31 18:35
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced U.S. Food and Drug Administration (FDA) clearance of MiniMed Flex™, a next-generation discreet, smartphone-controlled insulin pump
03-18 21:08
NORTHRIDGE, Calif., March 9, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED) today announced the closing of its previously announced initial public offering (IPO) of 28,000,...
03-10 04:59
NORTHRIDGE, Calif., March 6, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in diabetes management, will begin trading on the Nasdaq Global Select Market (...
03-06 22:00
MiniMed Group, Inc (NASDAQ:MMED) IPO will take place March, 06 on the NASDAQ ex...
03-05 23:00